Larimar Therapeutics, Inc.
NASDAQ:LRMR
7.36 (USD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -36.949 | -35.355 | -50.636 | -42.482 | -23.132 | -61.368 | -52.028 | -57.878 | -74.286 | -36.478 |
| Depreciation & Amortization
| 0.311 | 0.318 | 0.326 | 0.155 | 0.078 | 0.261 | 0.188 | 0.212 | 0.07 | 0.016 |
| Deferred Income Tax
| -8.64 | 0 | 0 | 0 | 3.633 | -9.627 | 0 | 0 | -8.582 | -0.815 |
| Stock Based Compensation
| 7.615 | 6.619 | 5.473 | 2.161 | 0.129 | 0.173 | 0 | 0 | 8.582 | 1.553 |
| Change In Working Capital
| -2.511 | 1.669 | 2.747 | -2.043 | 0.226 | 0.593 | -0.099 | -5.496 | 6.729 | 0.815 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 1.288 | -0.666 | -0.553 | 0.97 | -1.014 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | -1.288 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.403 | 0.026 | -0.974 | -3.288 | 2.63 | 0.432 | -0.448 | 4.923 | 4.914 | 0.815 |
| Other Working Capital
| -2.108 | 1.643 | 3.721 | 1.245 | -2.404 | 0.827 | 0.454 | -6.466 | 7.743 | -0.815 |
| Other Non Cash Items
| 6.715 | -0.82 | -0.015 | 0.01 | -3.633 | 9.783 | 9.084 | 10.641 | 9.087 | 6.668 |
| Operating Cash Flow
| -33.459 | -27.569 | -42.105 | -42.199 | -22.699 | -51.487 | -43.784 | -51.975 | -59.554 | -28.241 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.164 | -0.1 | -0.333 | -0.062 | -0.083 | -0.108 | -0.055 | -0.66 | -0.595 | -0.058 |
| Acquisitions Net
| -0.034 | 0.091 | -0.025 | -1.296 | -26.027 | 6.759 | 0 | 0 | 91.504 | 0 |
| Purchases Of Investments
| -101.233 | -133.61 | -8.248 | -24.486 | -82.861 | -117.147 | -114.511 | -136.528 | -287.491 | -57.2 |
| Sales Maturities Of Investments
| 134.75 | 42.75 | 32.75 | 1 | 109.471 | 110.388 | 150.213 | 188.6 | 195.987 | 0 |
| Other Investing Activites
| 0.034 | -0.091 | 0.025 | 41.934 | -0.583 | -6.759 | 35.702 | 0.035 | -0.019 | -0.057 |
| Investing Cash Flow
| 33.353 | -90.96 | 24.169 | 17.09 | -0.083 | -6.867 | 35.647 | 51.447 | -92.118 | -57.315 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | -16.367 | -2.935 | -1.381 | 0 |
| Common Stock Issued
| 0.03 | 75.257 | 19.885 | 75.592 | 19.395 | 66.908 | 0.195 | 0.22 | 130.545 | 3.569 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 67.22 | 0.195 | 0.22 | 131.018 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0.075 | 0.02 | 17.995 | 19.395 | 12.082 | 16.367 | -2.935 | -1.854 | 104.573 |
| Financing Cash Flow
| 0.03 | 75.257 | 19.885 | 93.587 | 19.395 | 66.908 | 16.562 | -2.715 | 129.164 | 108.142 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -58.103 | 0 |
| Net Change In Cash
| -0.076 | -43.272 | 1.949 | 68.478 | -3.387 | 8.554 | 8.425 | -3.243 | -22.508 | 22.586 |
| Cash At End Of Period
| 26.749 | 28.164 | 71.436 | 69.487 | 1.009 | 49.331 | 40.777 | 32.352 | 35.595 | 58.103 |